PORTACCIO, EMILIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.251
EU - Europa 7.165
AS - Asia 5.677
SA - Sud America 789
AF - Africa 136
OC - Oceania 89
Continente sconosciuto - Info sul continente non disponibili 5
Totale 26.112
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.122
RU - Federazione Russa 2.444
SG - Singapore 1.607
CN - Cina 1.469
PL - Polonia 1.339
IT - Italia 1.023
HK - Hong Kong 815
BR - Brasile 632
VN - Vietnam 569
SE - Svezia 531
IE - Irlanda 530
KR - Corea 514
FR - Francia 286
DE - Germania 266
FI - Finlandia 210
IN - India 181
UA - Ucraina 150
GB - Regno Unito 144
TR - Turchia 94
AU - Australia 89
BD - Bangladesh 83
JP - Giappone 75
JO - Giordania 66
AR - Argentina 63
CA - Canada 61
MX - Messico 46
ID - Indonesia 44
NL - Olanda 41
ES - Italia 38
CH - Svizzera 37
IQ - Iraq 35
ZA - Sudafrica 30
EC - Ecuador 27
CZ - Repubblica Ceca 23
CI - Costa d'Avorio 22
BE - Belgio 21
NG - Nigeria 20
CO - Colombia 19
IR - Iran 15
PK - Pakistan 15
VE - Venezuela 14
MA - Marocco 13
PH - Filippine 13
SC - Seychelles 11
UZ - Uzbekistan 11
AT - Austria 10
LT - Lituania 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
EG - Egitto 9
MK - Macedonia 9
PT - Portogallo 9
RS - Serbia 8
TH - Thailandia 8
BO - Bolivia 7
PA - Panama 7
AZ - Azerbaigian 6
BJ - Benin 6
CL - Cile 6
NP - Nepal 6
SA - Arabia Saudita 6
UY - Uruguay 6
BG - Bulgaria 5
DZ - Algeria 5
EU - Europa 5
HN - Honduras 5
KE - Kenya 5
MY - Malesia 5
PY - Paraguay 5
AL - Albania 4
HR - Croazia 4
HU - Ungheria 4
KZ - Kazakistan 4
AO - Angola 3
BH - Bahrain 3
CR - Costa Rica 3
CY - Cipro 3
GR - Grecia 3
IL - Israele 3
LU - Lussemburgo 3
SN - Senegal 3
DK - Danimarca 2
GE - Georgia 2
JM - Giamaica 2
LB - Libano 2
LK - Sri Lanka 2
NO - Norvegia 2
OM - Oman 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CV - Capo Verde 1
DM - Dominica 1
ET - Etiopia 1
GH - Ghana 1
Totale 26.094
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.390
Ashburn 1.383
Warsaw 1.328
Fairfield 1.310
Singapore 1.148
Hong Kong 690
Woodbridge 581
Dublin 530
Seattle 514
Seoul 504
Chandler 502
Cambridge 500
Houston 476
Wilmington 399
Hefei 342
Beijing 315
San Jose 288
Altamura 225
Jacksonville 221
Lawrence 215
Ann Arbor 200
Buffalo 192
Ho Chi Minh City 167
Princeton 152
Lauterbourg 145
The Dalles 140
Los Angeles 133
Hanoi 124
Florence 109
Moscow 109
Munich 104
Boston 98
Mumbai 97
New York 91
Melbourne 85
Boardman 78
Paris 76
Dallas 71
Milan 71
Kent 70
Medford 69
San Diego 62
Council Bluffs 61
Tokyo 60
Helsinki 56
Shanghai 55
Izmir 51
São Paulo 49
Dearborn 43
Orem 42
Turku 39
London 29
Norwalk 28
Rome 28
Chicago 27
Montreal 27
Chennai 26
Dong Ket 26
Bern 25
Clifton 25
Redondo Beach 23
Yubileyny 23
Abidjan 22
Bologna 22
Guangzhou 22
Jakarta 21
Da Nang 20
Haiphong 20
Abuja 19
Denver 19
Falls Church 19
Brooklyn 18
Phoenix 17
Andover 16
Biên Hòa 16
Brasília 16
Shenzhen 16
Turin 16
Atlanta 15
Barcelona 15
Bengaluru 15
Johannesburg 15
Tianjin 15
Brussels 14
Frankfurt am Main 14
Genoa 14
Hillsboro 14
Toronto 14
West Jordan 14
Brno 13
Mexico City 13
Quito 13
Rio de Janeiro 13
Amman 12
Lappeenranta 12
Baghdad 11
Bari 11
Belo Horizonte 11
Istanbul 11
San Francisco 11
Totale 17.636
Salva come PNG Salva come JPEG
Nome #
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population. 466
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 319
EPIDURAL ANALGESIA AND CESAREAN DELIVERY IN MULTIPLE SCLEROSIS POST PARTU RELAPSES: THE ITALIAN COHORT STUDY. 314
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. 301
Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis. 299
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study. 295
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 274
Improvement on the Coma Recovery Scale–Revised During the First Four Weeks of Hospital Stay Predicts Outcome at Discharge in Intensive Rehabilitation After Severe Brain Injury 274
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial. 261
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. 258
The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population. 244
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 244
Anxiety state affects information processing speed in patients with multiple sclerosis. 238
THE RAO'S BRIEF REPEATABLE BATTERY AND STROOP TEST: NORMATIVE VALUES WITH AGE, EDUCATION AND GENDER CORRECTIONS IN AN ITALIAN POPULATION. 235
Score on Coma Recovery Scale-Revised at admission predicts outcome at discharge in intensive rehabilitation after severe brain injury 226
Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors 215
A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. 214
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures. 212
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. 206
Causes of diplopia in the emergency department: diagnostic accuracy of clinical assessment and of head computed tomography 205
Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). 202
Pronounced Structural and Functional Damage in Early Adult Pediatric-Onset Multiple Sclerosis with No or Minimal Clinical Disability 197
Cognitive impairment in early stages of multiple sclerosis. 197
Aging process, adherence to Mediterranean diet and nutritional status in a large cohort of nonagenarians: Effects on endothelial progenitor cells 196
Cognitive impairment and event-related potentials in paediatric multiple sclerosis: 2-year study. 195
Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series 195
Multiple Sclerosis Progression and Relapse Activity in Children 194
BRAIN DAMAGE AS DETECTED BY MAGNETIZATION TRANSFER IMAGING IS LESS PRONOUNCED IN BENIGN THAN IN EARLY RELAPSING MULTIPLE SCLEROSIS. 194
Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study. 194
Aging with multiple sclerosis: prevalence and profile of cognitive impairment 191
Decannulation and improvement of responsiveness in patients with disorders of consciousness 190
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 189
Impact of cognitive impairment on coping strategies in multiple sclerosis. 189
Critical illness-polyneuromyopathy: functional impact after severe Acquired Brain Injuries 189
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis 183
Cognitive rehabilitation in children and adolescents with multiple sclerosis. 183
Changes in neuropsychological test performance over the workday in multiple sclerosis. 182
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 182
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases. 180
Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. 177
ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis. 175
Thrombotic Microangiopathy as a Life-Threatening Complication of Long-Term Interferon Beta Therapy for Multiple Sclerosis: Clinical Phenotype and Response to Treatment—A Literature Review 171
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome. 169
EEG and Coma Recovery Scale-revised prediction of neurological outcome in Disorder of Consciousness patients 169
Cognitive impairment in multiple sclerosis. 168
Are there protective treatments for cognitive decline in MS? 167
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes 167
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis. 166
Cognitive and psychosocial features of childhood and juvenile MS. 165
Association of Neocortical Volume Changes with Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis 165
Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study 165
NEOCORTICAL VOLUME DECREASE IN RELAPSING-REMITTING MULTIPLE SCLEROSIS WITH MILD COGNITIVE IMPAIRMENT. 164
Author response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks 164
Emotional and neutral verbal memory impairment in Multiple Sclerosis. 164
RESPONSE TO INTERFERON-BETA THERAPY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: A COMPARISON OF DIFFERENT CLINICAL CRITERIA. 162
Breastfeeding is not related to postpartum relapses in multiple sclerosis. 162
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta 162
Prognostic value of post-acute EEG in severe disorders of consciousness, using American Clinical Neurophysiology Society terminology 162
New natural history of interferon-b treated relapsing multiple sclerosis 161
Cerebrospinal fluid igm and oligoclonal igg bands in multiple sclerosis: A meta-analysis of prevalence and prognosis 161
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients with Primary Progressive Multiple Sclerosis 160
Experience with rituximab therapy in a real-life sample of multiple sclerosis patients 160
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis 158
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 158
Psychosocial issue in children and adolescents with multiple sclerosis. 158
Subclinical MS. Follow-up of four cases 154
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 154
The contribution of cerebrospinal fluid oligoclonal band sto the early diagnosis of multiple sclerosis 153
Cognitive reserve is a determinant of social and occupational attainment in patients with pediatric and adult onset multiple sclerosis 153
BENIGN MULTIPLE SCLEROSIS: COGNITIVE, PSYCHOLOGICAL AND SOCIAL ASPECTS IN A CLINICAL COHORT. 153
The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Can Protect Against Cognitive Impairment in Multiple Sclerosis 153
Cognitive changes in multiple sclerosis 152
Posterior brain damage and cognitive impairment in pediatric multiple sclerosis. 152
Coping strategies, cognitive impairment, psychological variables and their relationship with quality of life in multiple sclerosis. 151
Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. 151
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study 150
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis. 145
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs. 145
Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset 145
Sars-CoV2 infection in pregnant women with multiple sclerosis 144
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks 144
Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening 143
CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY 142
A first step towards preventive medicine in multiple sclerosis 141
Switching to second-line therapies in interferon- beta treated relapsing-remitting multiple sclerosis patients 140
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient. 139
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks 139
Maturational Trajectory of Processing Speed Performance in Pediatric Multiple Sclerosis 138
Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. 137
Cortical lesions in radiologically isolated syndrome 137
Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis 137
Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs. 136
Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis 136
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety. 135
Interobserver agreement on Poser's and the new McDonald's diagnostic criteria for multiple sclerosis. 135
Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort. 135
Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapies 135
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis 134
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 134
The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis. 133
Totale 18.207
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.504
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021191 0 0 0 0 0 0 0 0 0 0 81 110
2021/20221.032 41 110 89 31 31 42 61 62 52 41 210 262
2022/20232.605 259 589 119 159 176 433 341 136 261 13 74 45
2023/20241.042 53 103 164 84 92 76 48 182 17 84 98 41
2024/20256.989 268 725 379 996 1.946 1.011 110 350 377 224 263 340
2025/20267.746 1.016 1.165 832 739 1.060 315 817 492 491 531 288 0
Totale 26.324